AMCIL Limited (AMH) Earnings Call Transcript & Summary

July 31, 2025

Australian Securities Exchange AU Financials Capital Markets earnings 51 min

Earnings Call Speaker Segments

Operator

operator
#1

Good day, and welcome to the full-year financial results briefing for AMCIL. Right now, everyone is in listen-only mode. A presentation will come first, and after that we'll hold a question and answer session. Questions will be taken through the webcast. Should you wish to ask something when that time comes, please type your questions into the ask questions box located at the bottom of the webcast window. I'll now pass the presentation to Mr. Mark Freeman, Managing Director of AMCIL. Thank you. Over to you.

Mark Freeman

executive
#2

Good afternoon, everyone. My name is Mark Freeman, and I serve as CEO and Managing Director of AMCIL Ltd. I've also been the Portfolio Manager for AMCIL since assuming that position roughly 2.5 years back. Thank you for joining this briefing on our full-year results. Before anything else, I want to acknowledge the traditional owners and custodians of all the lands on which we're meeting today, and to pay my respects to elders past, present, and emerging. With me on today's webinar are Andrew Porter, our CFO, Matthew Rowe, our Company Secretary, and Geoffrey Driver, our General Manager of Business Development. This briefing draws on material that's available on the company's website. The presentation slides will advance automatically through the webcast. Please be aware that after the presentation, we'll have time for questions and answers. Using the tab at the bottom of the screen, you can submit a question through the webcast. We'll now turn to the slides. On slide two, there's a disclaimer, simply to note that our purpose here is to discuss the company. We aren't providing advice as such. At this point, we'll move into the results, and I'll hand over to Andrew Porter, our CFO, to talk through those.

Andrew Porter

executive
#3

Thanks, Mark, and good afternoon, everyone. If you're looking at the presentation on screen — and that's all of you — you'll see four boxes there. The profit for the year came in at $6.7 million. That's the box at the top left, down from $7.5 million in 2023. Dividends we received were lower, partly because we sold some of the higher yielding stocks and bought stocks with different growth profiles. In certain cases, such as our larger holdings like BHP, they cut their dividends during the year. Meanwhile, revenue from cash deposits rose, as you'd expect given what had been a rising interest rate environment. Gains on the trading portfolio were slightly lower this year. That was the profit. What that profit doesn't include, though, are the realized gains for the year. After tax, AMCIL had roughly $13.7 million in realized gains. AMCIL has a history of paying out a portion of those as part of its total dividends. This year is no different — the difference perhaps being that the amount is somewhat larger than in more recent years.

Andrew Porter

executive
#4

Alongside the standard final dividend of $0.025, a special dividend of $0.03 has been declared. So total dividends for the year come to $0.065, compared with $0.04 in the prior year. Portfolio return stands at 6.4%. While that trails the market's 15.1%, Mark will address that point later on. The management expense ratio — the cost of operating the business — sits at 56 basis points, unchanged from last year. In dollar terms, that equals $0.56 per $100 invested in AMCIL. On a regular basis, the board benchmarks against comparable investment vehicles to confirm those costs fall within the parameters the board considers appropriate. That exercise was undertaken again this year, and the board is comfortable that we remain a relatively low-cost investment vehicle. Turning to slide five, you'll be aware that AMCIL is currently trading at a discount to its net tangible asset. This is a challenge confronting the vast majority of listed investment companies right now. It isn't an issue unique to AMCIL. It is an issue for listed investment companies generally. The board is very conscious of this. Two things have eventuated this year as part of those efforts to examine what we can do to reduce the discount.

Andrew Porter

executive
#5

To start with, during the year the company carried out a share buyback, which offset shares issued under the DRP and the DSSP over that period. AICS, the entity supplying staff to AMCIL and the other LICs, has brought on a Business Development Manager who has been speaking with a range of investors and investor groups regarding the advantages of putting money into a vehicle such as AMCIL. In the end, even with those efforts, the share price is not something we can control, though the Board and management are acutely conscious of it. Of course, we'll gladly field questions in the Q&A later, but for now, I'll pass things back to Mark.

Mark Freeman

executive
#6

Thanks, Andrew. Moving on now to how the portfolio has performed and what we've been doing. We'll begin with performance, and these figures cover 1, 3, 5, and 10 years. AMCIL's performance is presented after expenses and also after tax. Clearly, up to this point, we hadn't paid out many franking credits that we'd been building up. We have, of course, announced a special dividend of $0.03, so franking isn't included until it has actually been paid out. That holds the performance back. That said, these aren't the kind of returns we want from AMCIL. I'll get to that shortly. We have a slide showing what the last 2.5 years have looked like, to give some perspective. During that 2.5-year stretch, the first couple of years were very strong. Since then, performance has slowed. There's been some rotation in the market. The market has had a bit of a run now, but it's interesting to look back and ask how we've done across the last 2.5 years. I'll come to that soon. Going back to what we do at AMCIL, it's a focused portfolio, and we've stayed consistent with our process throughout that period. It's a relatively low-cost product.

Mark Freeman

executive
#7

No performance fees exist. Directors and staff hold a substantial equity stake. Our aim is to maintain fairly low turnover in the portfolio, and we wish to remain invested in what I'd describe as quality stocks. We want to own businesses that are progressing. In the end, over the long term, share prices track profit growth. You need to hold stocks whose profits are expanding as time passes, and our frameworks were designed to achieve exactly that. Moving to the next slide, let me walk through our investment frameworks here — these were built to identify companies capable of growing profits as time passes. The traits of businesses that manage this are typically a unique set of assets or a leadership position within an industry. Firms that dominate their industry tend to have a strong propensity for generating high returns and expanding profits. Businesses possessing a sustainable competitive advantage. We are cautious about companies exposed to external risk factors. Sadly, we've held one of those in the portfolio during this period, and it simply illustrates how important these issues I'm describing really are, though I'll get to that shortly. Balance sheets matter critically.

Mark Freeman

executive
#8

A lot of firms have collapsed because their balance sheets were weak. Our preference is for businesses whose revenue comes in annuity-like streams, and we also want companies run by capable management teams. When you combine all of those elements, they typically produce a durable competitive edge. That tends to translate into strong returns on capital. Companies generating strong returns on equity usually deliver solid results across time. Doing that hands you plenty of cash to put back into the business, so you can keep fueling growth, keep taking market share, keep extending your leadership position — and all of that normally adds up to earnings growth and, in turn, value creation for shareholders over time. So do we want to purchase such companies when value appears? The ideal moment for that is getting in early on a quality growth stock that's emerging, or holding out for a meaningful price dislocation in a business that's more established or growing strongly, and making sure you seize those chances. Our setup is designed to try to seize opportunities. That's what fund management is all about. If you turn to some of the activity and apply that lens to it, we'll sell out of stocks when we believe they're entirely overvalued. We judged Commonwealth Bank to be in that situation, and I'll have charts on that up shortly.

Mark Freeman

executive
#9

During this year, at this point, we did hold Mineral Resources, Pexa, and Domino's. We got out of all of those since we felt they had problems relative to our framework, so we exited. PSC we held for a brief period, but then a takeover came along for it, which was good. With PWR Holdings, short-term worries arose, so we got out. Costco, as you can see, appears in the buy and sells. We took part in the IPO. That was a very small trading position. We traded out of it. As for some of our trimming — again, I have slides on several of these later in the presentation — Wesfarmers and the banks. We simply took a little off the top, along with some stocks that had run hard at that point, such as Goodman, Breville, and Netwealth. Whether this is good or bad I'm not sure, but we trimmed quite a bit at our recent high prices. In hindsight, we probably should have exited the lot, but we still believe that's a good business going forward. We did cut the position substantially. We added to a few of our existing holdings during the period in WiseTech, ARB, Block, and NEXTDC. A nice pullback in Cochlear gave us a chance to add to our holding there.

Mark Freeman

executive
#10

Moving on to the remaining acquisitions shown on the right, we'll cover those on later slides as the presentation continues. Now, shifting to the next slide, I suppose the aim here is to grasp what has happened to our portfolio across the past 2.5 years. As I mentioned, we genuinely haven't done much turnover of the portfolio during that stretch. The thing is, during the first two years, several of the names you see listed here enjoyed remarkable gains — Macquarie Technology, ARB, and Reece all reached extraordinarily high prices. In the last six months, a number of those have come back down to what I'd describe as probably more reasonable valuations. That's the reason we tend to ask: how does it look across those 2.5 years? The investment that has let us down most during this period is IDP Education. This was a business that did run into problems on a couple of aspects of our frameworks, especially outside influence, meaning governments. Government influence, it's fair to say, has affected that stock far more heavily than we anticipated at the time. The company does hold a strong leadership position. The market is highly fragmented. They keep gaining share, yet the sector has been — it's fair to say — brutal for the business. We will most likely keep holding the stock from this point, but adding to that position is not something we're looking to do.

Mark Freeman

executive
#11

Like I mentioned, Commonwealth Bank had exceptional growth. We've moved past that. If you go to the next slide, then to pick up, I suppose the point I've been trying to get across is that the portfolio has performed well over the last 2.5 years. The first two years were very strong, and over the last six months we've given back some of those gains. We test the quality of the transactions in the last financial year. Even though the portfolio wanted to perform, the transactions we did were still adding value to the portfolio, which is pleasing following our process. We've had some good buying last financial year from Block, Life360, EVT, Hub, and Sigma Healthcare. We keep focusing on quality opportunities to add to the portfolio. The two charts below, the chart on the left shows how the portfolio performance has gone over the last 2.5 years. This first slide is on a pre-tax basis. After management expense ratio, but pre-tax, portfolio is up 14.2%, index up 12.2%, and then after tax, up 14.1% against 13.6%, but with a lot of franking credits sitting there. I'll sort of check those numbers. Over that period, the index is up about 36%, the portfolio pre-tax, but after cost is up 43%.

Mark Freeman

executive
#12

I remain at ease — in fact, very much at ease — regarding how the portfolio is positioned. Our results never leave me satisfied, and the crucial thing is that we must keep delivering that performance going forward, which means staying disciplined about our process. My confidence is high that if we keep doing so, we will keep performing strongly relative to our benchmark. To go a bit deeper on a couple of those transactions from the past year, as I mentioned, we keep uncovering opportunities that fit within our frameworks. What matters is taking action on them. Sigma has proven to be a solid investment for us. We entered the stock at roughly $1.56. This is a company led by its founder. It holds a meaningful market position, a leading position, a category killer within that segment. A strong balance sheet, an excellent track record, ample room to grow, solid return on capital — it checks every box for us. We made that purchase, and it has performed well. Life360, which is the app on your phone that can track your location or your family's location, and also your luggage, if you'd like to do that. I use it that way on my phone. Once again, these carried many of the characteristics we seek. It was a founder-led company, expanding its business considerably.

Mark Freeman

executive
#13

This is a worldwide operation. There’s still a meaningful opportunity here. A robust balance sheet. Once more, it met every criterion we set, so we established a position at roughly $18.90. I believe it has reached $40 as of today. EVT, once again, we’re glad to consider opportunities throughout the market. This one was more of what we’d describe as a cyclical or asset-based situation. A founder-led company once more, a solid balance sheet, and we believed a few of their operations were sitting right at the bottom of the cycle. When you invest in cyclical businesses, the crucial thing is to purchase at the cycle’s trough. That’s what we did, and I think our entry was around $10.90, and it has delivered very well for us. I just wanted to mention the one we acquired at the end of last year, Technology One, which once again was initially a founder-led company, with annuity income streams, a strong balance sheet, high return on equity, a huge market position, customer churn below 1%, perfectly suited to our approach, and that has been a solid investment for us too. We remain committed to the process, and our deals have kept delivering value. As I mentioned, the letdown was IDP. Moving to the following slide, once again, it doesn’t need to be entirely about growth stocks.

Mark Freeman

executive
#14

Our position in Amcor is really based on the value we believe they can generate from the recent Berry acquisition. In the past, when this company has made an acquisition, they've done quite well at extracting synergies. Typically, that delivers a period of 2 to 3 years of solid earnings growth. The PE is very low. The yield is about 5.5%. That's still yet to come through. I think we're roughly around break even on that stock once you include the dividends we've received. Hopefully, we do get those synergies and the stock does start to creep up. We did buy some Region Group. The yield was around 6.5% when we bought it. I think the market's expecting 3%-4%. I think it might be like 2%-3%. Those sort of returns, we think that's an attractive opportunity to add to the portfolio. We're happy to look for value in income stocks as long as we think there's growth in cyclical stock, as long as we think that's at the bottom, as well as good quality emerging growth stocks that fit our frameworks. We'll just move to the next slide just to give a bit of color around perhaps why we've exited Commonwealth Bank and why we've held on to CSL through this period.

Mark Freeman

executive
#15

This chart is quite interesting, because when you look at the yellow bars for Commonwealth Bank, those represent earnings per share. Over time it's been fairly flat, yet the black line represents the share price. Even with a rather flat EPS profile, the share price has risen by roughly 70% while earnings growth has been very minimal. Over on the right, for CSL, the EPS growth — sorry, the last two bars reflect what the market is forecasting. CSL has delivered strong EPS growth, with forecasts pointing to that growth continuing, but the black line indicates the share price has been declining. That explains why we've kept holding CSL while we've exited Commonwealth Bank. Moving to the next slide, to round out the picture, this displays the PE — Commonwealth Bank's PE ratio over time. As you can see, for most of this period it has traded at a PE, or the average across this stretch is 20 times. Going back further than what's shown here, it's likely closer to 15 times. The PE has climbed to almost 30 times even though earnings growth has been flat. For CSL, even with a still solid earnings outlook, the PE has in fact fallen to 23 times.

Mark Freeman

executive
#16

To put it simply, CSL looks like solid value at current prices, while in our view Commonwealth Bank appears significantly overvalued. CSL remains in our portfolio; Commonwealth Bank we have sold out of. We recognize CSL represents a fairly sizable holding. Should the stock reach what I consider to be full or fair value, it is likely one we might trim somewhat as time goes on. Much the same applies to Wesfarmers. We have cut our Wesfarmers stake considerably. Like CBA, it is a wonderful business, well managed, with a strong market position. We genuinely like these companies. It comes down to valuation alone. Turning again to Wesfarmers on the left, looking at that PE across the long run, it is reasonable to call the PE extreme—that is the best description. The yield on the right paints much the same picture: getting a yield near 4%. Fully franked, that has now fallen to 2.7%. Given pricing of that extreme kind, despite it being an excellent company, we have meaningfully decreased our holding. Westpac is the next one, just to complete the picture. Among the banks, we still hold Westpac. We still hold some NAB, against which we have call options on both of those stocks, but we have shrunk those positions considerably for the same reason.

Mark Freeman

executive
#17

The valuations seem stretched. We are fielding a few inquiries regarding the reason for that and what is happening in the market. It is difficult to pin down, yet it simply feels as though buyers outnumber sellers, and it seems like capital is pursuing assets within particular segments, which I always find worrisome. In my view, when you genuinely sense that plenty of money is pursuing a specific stock or a market sector, it is frequently wise to move in the opposite direction. We hold the full portfolio here. I do not intend to walk through these stocks, but for the sake of completeness, we have displayed exactly how we think about our positions. Within the growth segment, we like—there are numerous names in there, but our way of thinking about it is this: it matters that if we identify a stock matching our frameworks and processes, the finest action available is to own it. The poorest action available is to avoid owning it, since we do not wish to attempt cherry-picking which ones will turn out to be the winners. You want a spread of stocks in order to try to ensure you capture the top growth opportunities, provided they match our frameworks.

Mark Freeman

executive
#18

Since I took over at AMCIL more than 2.5 years ago, the largest error we've committed wasn't failing to hold IDP — though its steep decline has been awful. The truly worst blunder was failing to own Prometheus, a company that in fact clears our frameworks. We want to acquire it and were attempting to be somewhat clever about the price. That represents a larger miss for us than holding IDP. We've genuinely absorbed that lesson — we must ensure we hold the quality stocks. That lesson has stuck with us, which explains our purchases of Life360, Sigma, and Technology One, for instance, and those have performed nicely for us. On the stalwarts, we're comfortable holding larger companies when they possess strong market positions and the capacity to expand. We're comfortable owning some income stocks when we can buy them at good prices, provided they can achieve some growth. As I mentioned before, call options let us enhance the yield available on certain of the slower-growing businesses. As I mentioned before, with cyclical asset plays such as Amcor and EVT, we're comfortable examining those. We hunt for value throughout the market across a range of segments.

Mark Freeman

executive
#19

We've included our top holdings simply to demonstrate that we remain a longer-term investor, which is exactly what we aim to be. A great many of these businesses have sat in the portfolio for a very long stretch. Broadly speaking, the reason we'd consider selling a stock is when the model begins to crack, and we discussed a few of those cases earlier. When something becomes too extreme, such as a CBA, we're probably more inclined to exit if we believe earnings will struggle to catch up with the valuation. With a strongly growing company that's overpriced, we might assume, yet we probably won't exit, since we tend to find that eventually earnings will catch up. We want to stay on board the businesses capable of delivering growth into the long term. Moving to the outlook at this point, we'll just start with a chart. Our stance on markets is generally more cautious. This is the PE of the ASX 200. It goes back 20 years, but if you took this chart back further, it'd still tell you the same picture. The PE is very high, and not just on the Australian market. You could do this on the U.S.

Mark Freeman

executive
#20

On that market too. Other measures you might consider—ones that can occasionally prove more revealing—include price to sales or perhaps price to book; the message they send is identical. Valuations sit at very high levels. Dividend yield is another metric worth watching. We're truly at extremes here. Once again, it feels as though capital is pursuing assets. Risk isn't something people are concerned about. Looking at these charts genuinely makes me uneasy. Right now we're keeping a modest cash position. Against certain holdings, we hold additional call options compared with what we typically carry. Our stance is likely closer to trimming unless an exceptional opportunity presents itself. Looking more widely, clearly there are numerous matters out there that, in my view, the market genuinely isn't accounting for. Tariffs have returned to the picture, and regarding that debate, the market appears to be overlooking it. Reporting season is approaching, and we're forming some impression that corporations feel somewhat more anxious regarding what lies ahead, given elevated valuations. As I mentioned, we're attempting to adopt a more defensive posture. Ultimately, we want assurance that our companies are financially strong and can grow profits across the long term.

Mark Freeman

executive
#21

We are going to keep following that same route. That brings the formal presentation to a close. At this point we are glad to take a few questions, and I will hand things over to Geoff.

Geoffrey Driver

executive
#22

Thanks, Mark. As a quick reminder for everyone, questions can be submitted through the bottom of the screen, and I'll respond to them in the question box there. I have several questions in front of me, Mark, and a couple of them are connected, so I'll group those together. Since AMCIL has fallen short of its objectives across 1, 3, 5, and 10 years, which measures have been put in place to enhance how the portfolio performs? Does the ongoing discount to NTA indicate weak investment results across those years? And what actions will be taken to lift investment performance?

Mark Freeman

executive
#23

I believe I've addressed the first question quite clearly during the presentation — you know, we're not pleased with the 1, 3, 5, and 10, and since we took over AMCIL, we've been sticking to a fairly disciplined approach that's been running for 2.5 years, and over that stretch we've been outperforming. We'll simply keep at it. Hopefully, with time, that starts showing up in the three-year figures and hopefully the five-year figures. On the NTA discount — look, it certainly doesn't do anything to help underperformance. We believe stronger performance will assist with that. We do observe these kinds of discounts market-wide at many LICs, not only ours. Obviously, we run four LICs. Three of them are trading at discounts. This one's larger, but plenty of other LICs in the market have them too. I think the entire sector is out of favor. I think AMCIL, being a smaller fund, also gets that larger discount. If you go back 3 to 4 years ago, many of these LICs were trading at premiums. It's interesting when we look at what happened roughly three months ago, when there was a big sell-off in the market.

Mark Freeman

executive
#24

The share prices of the LICs actually held up fairly well even though the market dropped quite a lot. Discounts narrowed significantly. It's a hot market, and historically we've observed that in such conditions, people tend to avoid products like LICs. We're working to educate the market further that we differ from many LICs out there. There's no external manager, no performance fees, and a relatively low management expense ratio across our groups. I think that point has probably been somewhat lost on the market. We're doing more marketing. We've brought on another resource within the group to, I guess, find new buyers of the stock. They do exist, but they're somewhat more fragmented. We're seeking financial planners who can, I guess, make decisions rather than just following some model portfolio. We're already getting some traction there. At the end of the day, the first step is simply to keep up the performance.

Andrew Porter

executive
#25

And keep in mind too, Mark, that half a year back, when AMCIL was posting results ahead of the market, your shares were still changing hands at a notable discount. That's something affecting the whole industry.

Mark Freeman

executive
#26

We are making an effort, but I still tend to think that for me this is simply one more indication of just how extreme the market is at these levels. In a sense, I believe people are likely being more rational when it comes to the LICs, and they are probably wary of chasing the market at these prices. We simply have to do whatever we can, and that likely means concentrating somewhat more on, you know, identifying the potential buyers, identifying the financial planning groups that are able to make their own decisions, and then approaching those people.

Geoffrey Driver

executive
#27

There's a question regarding CSL. I believe you've addressed this market through examples already, so on the matter of CSL — obviously, it has been affecting performance.

Mark Freeman

executive
#28

Right, we clearly just went through that in the presentation. They showed us the reasons we're positive on it — the EPS growth it's delivering and what we believe it can deliver ahead. It definitely fell out of favor once Trump took office, I think. There was plenty of anxiety about what would happen with pharmaceutical products. You likely had a situation where many Australian institutions already held a lot of the stock, yet it kept a lot of overseas buyers away. Now that things have calmed down somewhat, at least on that side, it seems like some buying is returning to the market. Only a few weeks back, the stock was down near $255. It has already rebounded to around $270 odd. We have the result coming up. Assuming that's fine, it looks like it's beginning to recover a little. If we see value in it, we're glad to keep holding. It comes down to earnings growth. The company had been fairly upfront about aiming to achieve double-digit EPS growth over the next few years. To me, that's pretty solid growth. That's why we're still invested.

Geoffrey Driver

executive
#29

Are you going to keep holding IDP?

Mark Freeman

executive
#30

Yeah, look, at this stage we probably will, since it still holds that leading position. You have to form a judgment. In hindsight, that was likely the peak of the cycle. The question now is whether we're at the trough — is this as bad as it gets for student placements? If that's the case, selling at the bottom isn't what you want. Getting there, I think, will require some patience. A useful illustration, thinking back, is that we held some PEX roughly a year ago. We exited PEX because we wanted to see certain management changes, and a great deal depended on the U.K., yet nothing suggested improvement. That thesis eventually began to work out. I've in fact repurchased into it, since they've now landed their first contract in the U.K. and there have been management changes. It does take time. Right now I think we'll remain in it, but it's one to watch quite carefully. That's in case we see any recovery in student volumes, because universities have leaned heavily on international students to fund the business, and removing that leaves them in an interesting position.

Mark Freeman

executive
#31

That gives us a fair amount to work through, but for the near term we're going to hold it regardless.

Geoffrey Driver

executive
#32

There's a question regarding the buyback. I suppose we halted repurchases after having one running earlier in the fiscal year. Will we consider repurchasing additional shares, and would we look to repurchase the DRP shares on market?

Mark Freeman

executive
#33

Okay, so that's — you know, we were repurchasing shares, and I think, I mean, this really sits with the board, but the way it was framed for us, for them, was especially about the first step being that DRP, because when the discount is that large, if you're seeing new stock at a discount, if you don't participate in it, it's diluting. To me, it makes sense to at least have an intent of buying that stock back. Whether you go beyond that, look, we have done a bit more and it didn't really close the gap, but it does add value if the market keeps going up. I think neutralizing the DRP kind of makes sense, but we'll make that decision, but it's potentially something we can do.

Geoffrey Driver

executive
#34

Thanks, Mark. I have a question about Transurban, I should say. It's held at 4.4% in the portfolio. Given its ongoing core metrics, ROE, its sort of debt, and modest insider ownership, does it look like a high-quality company across all four of those metrics?

Mark Freeman

executive
#35

Look, given the size of this company, you're never going to see substantial insider ownership. ROE really comes down to a function. This stock has to be viewed a bit differently, because this is a business where you sink an enormous amount of CapEx in on day one, and then gradually, as cash flows keep growing and growing, you ultimately earn the returns you're after. We know that when the company models out new investments, it aims for an appropriate return on capital or return on equity over time. That discipline, I think, is present. Those boxes, I think, get ticked. It holds a leadership position, a dominant market position. The yield sits at roughly 5% or so. We believe that could grow at 4% or 5%, which ought to make for a good sound investment. Not every stock will shoot the lights out, but we expect distribution growth to keep going. So long as we can capture distribution growth plus the dividend yield, it should be a solid investment. What we've been doing is that whenever it has little runs in share price, we step in and sell some call options against it, which then enhances the yield.

Mark Freeman

executive
#36

Through the option activity, we've been achieving a yield considerably higher than that. Provided we can continue doing so, that's fine. If better opportunities come along, this is likely something we could trim somewhat. The key is making sure we work the stock hard whenever those opportunities arise.

Geoffrey Driver

executive
#37

Thanks, Mark. With the quality-company investment framework we use, how do you explain the shareholder position in NEXTDC? Since they have consistently posted negative earnings, and projected losses for coming years are even larger, in what sense can this business be called growth, a growth stock, and what is the reason it sits in the portfolio?

Mark Freeman

executive
#38

Yeah, so that’s another solid question, since it flows directly out of Transurban. I’ve always looked at NEXTDC as actually being similar to the Transurban model, in that it’s infrastructure. You have to put all your capital in upfront, you know, hoping the business shows up afterward. If you look at Transurban’s long-term returns, they’ve actually been pretty good since the point where they listed. NEXTDC is the same. It’s building out a leadership position in Australia. I certainly think that now, if you want a data center and you’re a very large business, you’re going to be speaking to NEXTDC. What you’re starting to see now is that when they build out a data center, you’ve got to put all the capital in front. You’ve got to build it out. You don’t sign up the contracts until the end, but they’re only building out because they’re discussing with groups like Microsoft and Google and Amazon and all these types of companies. They get a pretty good feel for what they want. Certainly I’m pretty confident that when you speak to NEXTDC about modeling out, they want to get an appropriate return on capital. They price their data centers on that basis, but you don’t get it until it’s full.

Mark Freeman

executive
#39

That's a fascinating model. Our view is that they're now at a point where the share price has begun climbing, thanks to their having started announcing a handful of contract wins. Over the coming 2 years, I think you'll witness far more of that. The market will begin to appreciate more of the infrastructure they have constructed. What I watch for is that we continue pressing on the question: are they earning a suitable return on capital? Can they sustain growth as time goes on? With infrastructure stocks, one has to view them a bit differently.

Geoffrey Driver

executive
#40

There's a question about Soul Pattinson. Why isn't AMCIL putting money into Soul Pattinson? That stock happens to be the sole dividend aristocrat on the ASX. On top of that, Sol gives you exposure to both private equity and private credit.

Mark Freeman

executive
#41

We do genuinely appreciate the team behind it. The part I've found difficult, I'd say, is the valuation. It's a fascinating setup, since they've needed to expand that segment into private equity and private credit. That approach to investing is distinct, yet they appear to have executed it quite effectively. Because of that, it's a stock I follow rather closely. At its current level, though, the valuation gives me pause. Should that valuation grow more attractive, it would definitely be something I'd consider.

Geoffrey Driver

executive
#42

Thanks, Mark. Since we put money into both big and small businesses, do you split the portfolio into divisions—for example, measuring the ASX 200 names against that index, and the stocks beyond the 200 against a more suitable benchmark—or some comparable practical way of dividing things up?

Mark Freeman

executive
#43

I think we're sort of in AMCIL because we want to try and — I mean, most people think about the ASX 200. If I go into a, if I was looking at a mid-cap or small-cap fund, I'd be doing it, not trying to beat the smaller mid-cap fund. I'd be going in it and trying to beat the 200. That's why what we're trying to do in AMCIL, and that's sort of our expectation is that we can beat the 200. Now we can use mid and small-cap stocks to do it. That's okay, but we're just trying to beat the 200 over time.

Geoffrey Driver

executive
#44

Has AMCIL taken a look at certain retirement-sector stocks, for instance Lifestyle Communities and GemLife?

Mark Freeman

executive
#45

Yes, we do. It’s fair to say those models present us with several problems. One of the largest recently is simply the leverage they build into the portfolio. As I mentioned, when these companies began adding leverage, that made me quite concerned, since carrying that much debt places excessive financial risk into the model. They were eager to expand very fast in order to get there. Then, of course, an unfavorable tax ruling lands on top of that, which we would regard as an external factor. At this stage, it isn’t something we’re pursuing.

Geoffrey Driver

executive
#46

As AMCIL's dividend growth decelerates — and I suppose that's the broader market slowdown in dividend growth people are discussing — AMCIL ultimately resembles Mirrabooka, in that gains will be drawn upon to fund dividends.

Mark Freeman

executive
#47

That outcome reflects precisely what we set out to accomplish. We've generated considerable gains, and a substantial portion of those is being distributed through a special dividend.

Andrew Porter

executive
#48

That’s the way it’s always been at AMCIL.

Mark Freeman

executive
#49

Correct, that has been the situation. The dividend we refer to as ordinary exceeds earnings. As we've said, a modest amount of capital will come in to back it. Should we generate excess gains, then honestly, the board has decided that where those excesses are significant, we'll distribute them as a special.

Geoffrey Driver

executive
#50

Thanks, Mark. I’d like to add a few points regarding how the share price trades compared with NTA and how that might relate to portfolio performance. I suppose the real question is this: if that discount to NTA continues, would the board look at selling holdings or returning cash to shareholders?

Mark Freeman

executive
#51

That is once more a matter for the board to decide, though it isn't the subject we're discussing right now. What I mean is, we want to — we view this as somewhat different in terms of how we approach it. We believe there are other options potentially available to us regarding AMCIL. The most recent word I had from the board, which came only a short time ago, was that the intention was to keep it running. Their attention is on that 2.5-year figure. My understanding is they're saying simply to carry on with it.

Geoffrey Driver

executive
#52

Thanks, Mark. My question is about what we actually need to see from Woolworths for you to either keep your conviction or think about exiting it.

Mark Freeman

executive
#53

We're returning to decent EPS growth, and we believe they can achieve that from this point across the coming few years. In our view, it still holds the strongest footprint. Coles, I think, has performed excellently. Their CEO has been doing a great job. Coles is actually a name I examined a couple of years back, when they replaced their CEO, and I figured it might do well — and indeed it has. Woolworths we've kept holding. For them, things are looking somewhat improved when it comes to delivering EPS growth. I doubt it will ever be spectacular. To me it's more a stock that — you know, it's a solid business, provided it doesn't get too pricey. Two and a half years ago, the stock climbed very sharply and the PE sat very high, so we trimmed a great deal of it. We brought it down to an index position. Since then it has given back a lot. At these kinds of levels, we're comfortable holding it. Once more, it might be another name where you consider call options to make the stock work a bit harder. That's something I'm currently thinking about.

Geoffrey Driver

executive
#54

Is Signature Financial part of AMCIL's portfolio? And what's our view on whether that buyout will actually proceed?

Mark Freeman

executive
#55

No, that isn't ours. Honestly, it hasn't fit well with our frameworks at all. I'm not sure how that will turn out. It's not something I've concentrated on so far.

Geoffrey Driver

executive
#56

There's a question regarding Woodside. Is it an income trap, given all the expenses guarding your project commitments?

Mark Freeman

executive
#57

Sure, that's the key question. It's what I'm asking myself right now: how capable are they of actually growing earnings? Given some of the projects they have underway, we believe they can grow earnings from here. With the yield and the franking, provided they can achieve a bit of growth over time, then it's fine. That's the test I keep applying to this stock. The sell-off was pretty dramatic, and I think it was starting to look at pretty value. That's the test we keep applying to that one: we need the yield and the franking plus some earnings growth to keep it in the portfolio. Right now, we do think we'll get some earnings growth, but that's the test for that one.

Geoffrey Driver

executive
#58

So, do you think Redox’s underperformance is just a temporary thing?

Mark Freeman

executive
#59

I certainly hope so. That's one I moved on fairly quickly, I think. In case anyone isn't familiar, this is a distribution business. A family-run, owner-led company that went public a couple of years ago. They distribute a variety of chemicals and products used in an enormous number of applications — it's remarkable. Take shampoo, for instance: plenty of ingredients are needed to make it. If you look at the back of the bottle, most of those would likely be supplied by Redox. They bring these ingredients in from all over the world and then distribute them to makers of a wide array of agricultural and pharmaceutical products. Their market position in Australia is very strong. I'd describe it as a leadership position within a fragmented market. They make acquisitions on a regular basis. Over 20 years, the revenue growth track record has been excellent. They pay fully franked dividends, which is a positive. We took a smaller position, though I suspect we probably bought at the wrong time. I'm not certain how good the next result will be, but right now I'm backing that 20-year track record and the idea that they can keep doing what they've been doing.

Mark Freeman

executive
#60

I've stopped making further purchases, so my guess is we'll simply sit tight, though I don't anticipate much over the near term. As I mentioned, since it's a family-operated company, we believe they understand their operations well, but their business does move through a cycle. For now, we'll remain in place.

Geoffrey Driver

executive
#61

There's another question regarding what we hold in the portfolio. What makes ReadyTech so appealing?

Mark Freeman

executive
#62

Yeah, we're in a comparable spot, most likely. We established a modest stake there. It has kind of slipped back somewhat once more. Those two were likely acquired by us somewhat late in the cycle. ReadyTech is a business led by its founders. They are basically a software firm. Products are what they sell. Relative to Technology One, they compete at the lower end, sort of. Their products go mainly into TAFEs — TAFEs and universities, though the smaller ones. Revenue streams are of the annuity type. Generally, customers stay put, although a customer was lost by them recently, and that didn't please us. There still appear to be ample opportunities available to them. Those traits centered on annuity revenue and founder leadership. Our impression was that many opportunities to grow would emerge, though over the short term it has probably been somewhat disappointing. Once again, we aren't adding to it; we'll simply hold from here on. Each one, I believe, sits at roughly 0.5%, and one is around 0.7% of that order.

Geoffrey Driver

executive
#63

Thanks, Mark. I see we're nearly out of the questions I have here. With NEXTDC and Goodman Group, water supply and residential water quality could turn into a problem, since a cooling operation needs a great deal of water. That's clearly the case for the data centers.

Mark Freeman

executive
#64

Right, so water and power are indeed needed. At this moment I’m not seeing any of those issues, since essentially they must obtain development approvals from local councils. In those submissions, they have to address all the power, water — all those issues must be handled there. They’re quite strict. I’ll take that away, but it’s something we’re probably not seeing right now.

Geoffrey Driver

executive
#65

Yes, I believe that question was directed at Africa, and I've already sent back an answer. Right, there's a question here, and it's a really good one. How do you think about balancing a high-growth portfolio at a moment when a lot of growth stocks in the market have run up sharply?

Mark Freeman

executive
#66

Sure, that's a fair question. My preference is always to hold a high-quality growth business that's gotten expensive, because while it may go sideways for a while, the earnings can eventually catch up. Looking at the whole market, it's simple to just concentrate on quality growth and conclude, "Well, those names are too pricey." I don't see them as more overpriced than plenty of other stocks out there. Take the banks, which make up over 20% of the market — they'd be just as overvalued as the growth names. In fact, when you examine what quality growth really means, we'd point to Macquarie Technology, which is probably closer to fair value. We see ARB as having been nearer fair value too, even though it's bounced off its low point. CSL, in our view, is fair value. Within that quality growth bucket, we believe a number of stocks are fairly valued. Naturally, a few will always look extreme, but you can't own every stock. That's the reason our portfolio is priced precisely the way you'd want it to be. It simply doesn't work otherwise. Westfarmers is another name that looks more overpriced than any of those growth stocks.

Mark Freeman

executive
#67

Focusing on just one segment and claiming that's where overpricing exists is a mistake. In fact, looking at even what we've seen more recently, the high-quality names often aren't the ones that cause you trouble. It's the ones hit with big downgrades. Frequently that can be a cyclical stock that gets a downgrade, or a lesser quality stock that appears to have problems with something, causing it to fall further. It's a portfolio approach.

Geoffrey Driver

executive
#68

On the subject of shares that could be pricey, Wesfarmers — is it nearing expensive territory in the market right now?

Mark Freeman

executive
#69

Right, that was addressed during the presentation on the slide where the PEs appeared quite extreme. Our position has been cut in half, and against a fair chunk of what remains we hold call options. You always face the question, you know — do you exit it or not? We're putting that position to work harder than we have been, and it's much more than what we had.

Geoffrey Driver

executive
#70

There's a question regarding the PE reviews for CSL and the way that particular figure has been computed, since it appears we're relying on earnings that are based on — and that's a separate calculation from the one the same NAB trade has on its website.

Mark Freeman

executive
#71

It really hinges on which earnings figure you’re looking at, since the earnings they report are denominated in U.S. dollars. What you have to do first is convert that back into Australian dollars, and then compare the Australian price against the Australian-dollar figure — that’s how you arrive at that PE.

Andrew Porter

executive
#72

My view is that we won't see a 20% decline in earnings next year.

Mark Freeman

executive
#73

Profits are climbing. Market consensus points to double-digit EPS growth across the coming two years.

Andrew Porter

executive
#74

You can find that on the slide.

Mark Freeman

executive
#75

Yes, that matches what the slide shows.

Geoffrey Driver

executive
#76

All right, Mark, I don't have anything else to ask, so I figure I'll hand it over to you for the closing. We're at almost an hour now, and viewer count is dropping, so let's wrap it up at that point.

Mark Freeman

executive
#77

To put that in a nutshell, even though the 1-year figure appears quite weak, it really stems from having 2 exceptionally strong years, and then during the last 6 months, a few of our holdings have surrendered some gains, but we truly haven't—we remain pleased with the positions we hold. The work we're engaged in continues to create value, and we genuinely believe we're adhering to the approach we committed to implementing 2.5 years ago. From my perspective, it's simply staying disciplined and ensuring we own high-quality stocks. A major element of our efforts involves ensuring we seize opportunities when they arise. That is an essential aspect of managing a successful portfolio. Hopefully, over time, you'll witness those figures beginning to convert into the results we disclose to the market. We appreciate all of you for joining this call.

Geoffrey Driver

executive
#78

Appreciate it, Mark.

Operator

operator
#79

I appreciate that. That brings today’s webinar to a close. We’re grateful for your participation. Taking a wider view.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete AMCIL Limited transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to AMCIL Limited earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in AMCIL Limited or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.